Farnesyl diphosphate

Farnesyl diphosphate is a lipid of Prenol Lipids (PR) class. Farnesyl diphosphate is associated with abnormalities such as Dental caries and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Regulation, Process, Signal, Anabolism and inhibitors. Farnesyl diphosphate often locates in peroxisome, Cytoplasmic matrix, Plasma membrane, soluble and Mitochondria. The associated genes with Farnesyl diphosphate are HSD3B1 gene, ABRA gene, MATN1 gene, SEPSECS gene and MBD2 gene. The related lipids are Sterols, 22-hydroxycholesterol, dehydrosqualene, SK&F 104976 and 25-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of Farnesyl diphosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Farnesyl diphosphate?

Farnesyl diphosphate is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Farnesyl diphosphate

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Endometriosis D004715 29 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Protozoan Infections D011528 6 associated lipids
Osteosarcoma D012516 50 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with Farnesyl diphosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Farnesyl diphosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Farnesyl diphosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Farnesyl diphosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Farnesyl diphosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Farnesyl diphosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Farnesyl diphosphate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Farnesyl diphosphate

Download all related citations
Per page 10 20 50 100 | Total 614
Authors Title Published Journal PubMed Link
Thelin A et al. Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids. 1994 Biochim. Biophys. Acta pmid:7811707
Liliom K et al. Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs. 2006 Biochim. Biophys. Acta pmid:17092771
Raisig A and Sandmann G Functional properties of diapophytoene and related desaturases of C(30) and C(40) carotenoid biosynthetic pathways. 2001 Biochim. Biophys. Acta pmid:11566453
Koyama T et al. Substrate specificity of squalene synthetase. 1980 Biochim. Biophys. Acta pmid:7357018
Keller RK Squalene synthase inhibition alters metabolism of nonsterols in rat liver. 1996 Biochim. Biophys. Acta pmid:8908150
Sagami H et al. The biosynthesis of dehydrodolichyl phosphates by rat liver microsomes. 1989 Biochim. Biophys. Acta pmid:2930770
Newman P et al. Polyisoprenylation of the CAAX motif--an in vitro protein synthesis study. 1991 Biochim. Biophys. Acta pmid:1954230
Exnowitz F et al. NMR for direct determination of K(m) and V(max) of enzyme reactions based on the Lambert W function-analysis of progress curves. 2012 Biochim. Biophys. Acta pmid:22079737
Ericsson J et al. Biosynthesis of dolichol and cholesterol in rat liver peroxisomes. 1993 Biochimie pmid:8507678
Troutman JM et al. Tools to analyze protein farnesylation in cells. 2005 Sep-Oct Bioconjug. Chem. pmid:16173800
Dozier JK et al. Engineering protein farnesyltransferase for enzymatic protein labeling applications. 2014 Bioconjug. Chem. pmid:24946229
Sinensky M and Lutz RJ The prenylation of proteins. 1992 Bioessays pmid:1546978
Sokalska A et al. Simvastatin decreases invasiveness of human endometrial stromal cells. 2012 Biol. Reprod. pmid:22492974
Rzepczynska IJ et al. Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat. 2009 Biol. Reprod. pmid:19571257
Goalstone ML et al. Characterization of Xenopus laevis oocyte farnesyl transferase. 1996 Biol. Reprod. pmid:8835391
Ortega I et al. Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. 2012 Biol. Reprod. pmid:21918126
da Costa BM et al. Regulation of rubber biosynthetic rate and molecular weight in Hevea brasiliensis by metal cofactor. 2005 Jan-Feb Biomacromolecules pmid:15638531
Fairlamb IJ et al. Synthesis and antimicrobial evaluation of farnesyl diphosphate mimetics. 2003 Bioorg. Chem. pmid:12697170
Teng KH and Liang PH Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis. 2012 Bioorg. Chem. pmid:21993493
Holstein SA et al. Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase. 1998 Bioorg. Med. Chem. pmid:9681134
Eummer JT et al. Novel limonene phosphonate and farnesyl diphosphate analogues: design, synthesis, and evaluation as potential protein-farnesyl transferase inhibitors. 1999 Bioorg. Med. Chem. pmid:10218815
Henry O et al. A versatile photoactivatable probe designed to label the diphosphate binding site of farnesyl diphosphate utilizing enzymes. 2009 Bioorg. Med. Chem. pmid:19447628
Duez S et al. Towards the synthesis of bisubstrate inhibitors of protein farnesyltransferase: Synthesis and biological evaluation of new farnesylpyrophosphate analogues. 2010 Bioorg. Med. Chem. pmid:20036564
Christensen DJ and Poulter CD Enzymatic synthesis of isotopically labeled isoprenoid diphosphates. 1994 Bioorg. Med. Chem. pmid:7858969
Scholten JD et al. Inhibitors of farnesyl:protein transferase--a possible cancer chemotherapeutic. 1996 Bioorg. Med. Chem. pmid:8894110
Feld BK and Weiss GA Convenient methods for the synthesis of P1-farnesyl-P2-indicator diphosphates. 2006 Bioorg. Med. Chem. Lett. pmid:16406516
Zhou C et al. Aromatic farnesyl diphosphate analogues: vinyl triflate-mediated synthesis and preliminary enzymatic evaluation. 2002 Bioorg. Med. Chem. Lett. pmid:11992789
Lannuzel M et al. From pure FPP to mixed FPP and CAAX competitive inhibitors of farnesyl protein transferase. 2003 Bioorg. Med. Chem. Lett. pmid:12668012
Zahn TJ et al. Grignard-mediated synthesis and preliminary biological evaluation of novel 3-substituted farnesyl diphosphate analogues. 2000 Bioorg. Med. Chem. Lett. pmid:10937743
Troutman JM et al. Synthesis of acyloxymethyl ester prodrugs of the transferable protein farnesyl transferase substrate farnesyl methylenediphosphonate. 2004 Bioorg. Med. Chem. Lett. pmid:15341963
Liu XH and Prestwich GD Didehydrofarnesyl diphosphate: an intrinsically fluorescent inhibitor of protein farnesyltransferase. 2004 Bioorg. Med. Chem. Lett. pmid:15080995
Jennings BC et al. Analogs of farnesyl diphosphate alter CaaX substrate specificity and reactions rates of protein farnesyltransferase. 2016 Bioorg. Med. Chem. Lett. pmid:26803203
Peukert S et al. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones. 2008 Bioorg. Med. Chem. Lett. pmid:18295483
Fujikura K et al. Kinetic studies of Micrococcus luteus B-P 26 undecaprenyl diphosphate synthase reaction using 3-desmethyl allylic substrate analogs. 2008 Biosci. Biotechnol. Biochem. pmid:18323637
Karunagoda RP et al. Labeling patterns of chloroplastidic isoprenoids in cultured cells of liverwort Ptychanthus striatus. 2001 Biosci. Biotechnol. Biochem. pmid:11440120
Koyama T Molecular analysis of prenyl chain elongating enzymes. 1999 Biosci. Biotechnol. Biochem. pmid:10586494
Wang C et al. Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. 2010 Biotechnol. Bioeng. pmid:20552672
Martin VJ et al. The in vivo synthesis of plant sesquiterpenes by Escherichia coli. 2001 Biotechnol. Bioeng. pmid:11745124
Takahashi S et al. Metabolic engineering of sesquiterpene metabolism in yeast. 2007 Biotechnol. Bioeng. pmid:17013941
Mendez-Perez D et al. Production of jet fuel precursor monoterpenoids from engineered Escherichia coli. 2017 Biotechnol. Bioeng. pmid:28369701
Asadollahi MA et al. Enhancement of farnesyl diphosphate pool as direct precursor of sesquiterpenes through metabolic engineering of the mevalonate pathway in Saccharomyces cerevisiae. 2010 Biotechnol. Bioeng. pmid:20091767
Paradise EM et al. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. 2008 Biotechnol. Bioeng. pmid:18175359
Lindahl AL et al. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. 2006 Biotechnol. Lett. pmid:16614895
Qian J et al. Positive selection and functional divergence of farnesyl pyrophosphate synthase genes in plants. 2017 BMC Mol. Biol. pmid:28160774
Eberlein M et al. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). 2001 Br. J. Pharmacol. pmid:11487529
Liu H et al. Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. 2009 Cancer Chemother. Pharmacol. pmid:18766339
Gopalan A et al. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. 2013 Cancer Lett. pmid:22960596
Nakajima H et al. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate. 2007 Cancer Lett. pmid:17316980
Finlay GA et al. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. 2007 Cancer Res. pmid:17942919
Tsubaki M et al. Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits macrophage inflammatory protein 1 alpha expression and secretion in mouse myeloma cells. 2008 Cancer Sci. pmid:17979996
Lujan DK et al. Chemoenzymatic synthesis of an isoprenoid phosphate tool for the analysis of complex bacterial oligosaccharide biosynthesis. 2012 Carbohydr. Res. pmid:22925763
Liang YJ et al. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products. 2008 Cardiology pmid:18057884
Takata R et al. Cerivastatin-induced apoptosis of human aortic smooth muscle cells through partial inhibition of basal activation of extracellular signal-regulated kinases. 2004 Jan-Feb Cardiovasc. Pathol. pmid:14761784
Crespo J et al. Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation. 2005 Cardiovasc. Res. pmid:16005304
Camino-López S et al. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells. 2007 Cardiovasc. Res. pmid:17141748
Reiss Y et al. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. 1990 Cell pmid:2194674
Agabiti SS et al. Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation. 2017 Cell Death Dis pmid:28300835
Zhao J et al. Farnesylation of p21 Ras proteins in Xenopus oocytes. 1994 Cell. Mol. Biol. Res. pmid:7866432
Morofuji Y et al. Pitavastatin strengthens the barrier integrity in primary cultures of rat brain endothelial cells. 2010 Cell. Mol. Neurobiol. pmid:20127168
Yang J et al. Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats. 2016 Cell. Physiol. Biochem. pmid:27336844
Valente AJ et al. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. 2013 Cell. Signal. pmid:23541442
Hovlid ML et al. Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stability. 2010 Chem Biol Drug Des pmid:19954434
Goeke A et al. A novel approach to prezizaane sesquiterpenes. 2004 Chem. Biodivers. pmid:17191831
Hu Y et al. Genome mining in Streptomyces clavuligerus: expression and biochemical characterization of two new cryptic sesquiterpene synthases. 2011 Chem. Biol. pmid:21276937
Deligeorgopoulou A et al. Stabilisation of eudesmane cation by tryptophan 334 during aristolochene synthase catalysis. 2003 Chem. Commun. (Camb.) pmid:13678181
Forcat S and Allemann RK Dual role for phenylalanine 178 during catalysis by aristolochene synthase. 2004 Chem. Commun. (Camb.) pmid:15367991
Kawasaki Y et al. Thermodynamic evaluation of the binding of bisphosphonates to human farnesyl pyrophosphate synthase. 2014 Chem. Pharm. Bull. pmid:24172032
Subramanian T et al. Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity. 2008 Chembiochem pmid:18985644
Lopez-Gallego F et al. Sesquiterpene synthases Cop4 and Cop6 from Coprinus cinereus: catalytic promiscuity and cyclization of farnesyl pyrophosphate geometric isomers. 2010 Chembiochem pmid:20419721
Faraldos JA et al. Interception of the enzymatic conversion of farnesyl diphosphate to 5-epi-aristolochene by using a fluoro substrate analogue: 1-fluorogermacrene A from (2E,6Z)-6-fluorofarnesyl diphosphate. 2007 Chembiochem pmid:17886322
Nguyen UT et al. Exploiting the substrate tolerance of farnesyltransferase for site-selective protein derivatization. 2007 Chembiochem pmid:17279592
Miller DJ et al. Aristolochene synthase-catalyzed cyclization of 2-fluorofarnesyl-diphosphate to 2-fluorogermacrene A. 2007 Chembiochem pmid:17683054
Hernández-Perera O et al. Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells. 2000 Circ. Res. pmid:11009568
Campbell M et al. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. 2004 Circ. Res. pmid:15242975
Guijarro C et al. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. 1998 Circ. Res. pmid:9734471
Han KH et al. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. 2005 Circulation pmid:15781755
Davis ME and Harrison DG Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production. 2001 Circulation pmid:11136674
Chatani Y [Minodronic acid hydrate as a new therapeutic agent for osteoporosis]. 2005 Clin Calcium pmid:15632466
Bhardwaj S et al. Muscular effects of statins in the elderly female: a review. 2013 Clin Interv Aging pmid:23355775
Agarwal B et al. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. 1999 Clin. Cancer Res. pmid:10473109
van de Donk NW et al. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth. 2005 Clin. Cancer Res. pmid:15701825
Yokota K et al. Geranylgeranyl-pyrophosphate regulates secretion of pentraxin 3 and monocyte chemoattractant protein-1 from rheumatoid fibroblast-like synoviocytes in distinct manners. 2011 Jan-Feb Clin. Exp. Rheumatol. pmid:21345291
Massy ZA et al. Regulation of mesangial cell proliferation by the mevalonate pathway. 1997 Contrib Nephrol pmid:9257061
O'Donnell MP et al. Isoprenoids, Ras and proliferative glomerular disease. 1997 Contrib Nephrol pmid:9257064
Mahmoodi MM et al. Chemoenzymatic site-specific reversible immobilization and labeling of proteins from crude cellular extract without prior purification using oxime and hydrazine ligation. 2013 Curr Protoc Chem Biol pmid:23839992
Ayral-Kaloustian S and Salaski EJ Protein farnesyltransferase inhibitors. 2002 Curr. Med. Chem. pmid:12733981
Vervacke JS et al. Photoactive analogs of farnesyl diphosphate and related isoprenoids: design and applications in studies of medicinally important isoprenoid-utilizing enzymes. 2013 Curr. Med. Chem. pmid:23409719
Zhang J et al. Statins directly suppress cytokine production in murine intraepithelial lymphocytes. 2013 Cytokine pmid:23290865
Pant A and Kocarek TA Role of Phosphatidic Acid Phosphatase Domain Containing 2 in Squalestatin 1-Mediated Activation of the Constitutive Androstane Receptor in Primary Cultured Rat Hepatocytes. 2016 Drug Metab. Dispos. pmid:26700959
Gromov PS et al. Identification of isoprenyl modified proteins metabolically labeled with [3H]farnesyl- and [3H]geranylgeranyl-pyrophosphate. 1996 Electrophoresis pmid:8982605
Weivoda MM and Hohl RJ Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation. 2011 Endocrinology pmid:21586555
Martínez-Sales V et al. Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells. 2007 Jul-Oct Endothelium pmid:17922340
Giglio S et al. Isolation and characterization of the gene associated with geosmin production in cyanobacteria. 2008 Environ. Sci. Technol. pmid:19031897
Vega-Pérez JM et al. Isoprenyl-thiourea and urea derivatives as new farnesyl diphosphate analogues: synthesis and in vitro antimicrobial and cytotoxic activities. 2012 Eur J Med Chem pmid:23174318
Burgazli KM et al. The effects of different types of statins on proliferation and migration of HGF-induced Human Umbilical Vein Endothelial Cells (HUVECs). 2013 Eur Rev Med Pharmacol Sci pmid:24254555
Ericsson J et al. Characterization and distribution of cis-prenyl transferase participating in liver microsomal polyisoprenoid biosynthesis. 1991 Eur. J. Biochem. pmid:1765092
Mau CJ et al. Protein farnesyltransferase inhibitors interfere with farnesyl diphosphate binding by rubber transferase. 2003 Eur. J. Biochem. pmid:14511375
Maccarrone M et al. Cholesterol, but not its esters, triggers programmed cell death in human erythroleukemia K562 cells. 1998 Eur. J. Biochem. pmid:9578467
Parmryd I et al. Identification of spinach farnesyl protein transferase. Dithiothreitol as an acceptor in vitro. 1995 Eur. J. Biochem. pmid:8575428
Tahir SK et al. Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue. 2000 Eur. J. Cancer pmid:10854950